Japan’s Rohto Pharmaceutical is partnering with Tsubota Laboratory for research and developement of a new myopia management eye drop solution. The eye drops, which were successfully tested on mice according to an article by Nikkei Asia, aims at slowing myopia progression by suppressing the thinning of the sclera, thereby reducing ...
Buying a membership today will give you:
To continue reading this article register now.